Original Literature | Model OverView |
---|---|
Publication
Title
Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs andCTRPs.
Affiliation
Department of Internal Medicine I, University of Regensburg, D-93042 Regensburg,Germany. andreas.schaeffler@klinik.uni-regensburg.de
Abstract
Adipose tissue has long been regarded as a mostly resting tissue that isdedicated solely to energy storage and release. However, in recent years, thisview has changed dramatically following new insights into the metabolic andimmunological functions of preadipocytes and adipocytes. There are several linesof evidence for the involvement of adipose tissue in innate and acquired immuneresponses. First, adipocytes are potent producers of proinflammatory cytokines,such as interleukin-6 and tumor necrosis factor (TNF), and chemokines.Furthermore, adipocytes secrete high amounts of adipokines, such as leptin,adiponectin and resistin, that regulate monocyte/macrophage function, and alsosecrete molecules associated with the innate immune system, such as theC1qTNF-related protein superfamily. Finally, preadipocytes and adipocytesexpress a broad spectrum of functional Toll-like receptors and the former canconvert into macrophage-like cells. Collectively, these data clearly establishthe role of adipose tissue as a new member of the immune system.
PMID
17681884
|
Entity
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
--
e11
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeMembrane
--
--
--
csml-variable:Double
m11
0
infinite
0
--
TLR9
--
e12
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m12
0
infinite
0
--
csml-variable:Double
m13
0
infinite
0
--
TLR9:CpG oligodeoxynucleotide
--
e14
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m14
0
infinite
0
--
TLR2
--
e15
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m15
0
infinite
0
--
Pam3Cys
--
e16
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m16
0
infinite
0
--
TLR2:Pam3cys
--
e17
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m17
0
infinite
0
--
csml-variable:Double
m18
0
infinite
0
--
TLR
--
e19
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
TLR4:LPS
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
IL-6
--
e21
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m21
0
infinite
0
--
IL-6
--
e22
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m22
0
infinite
0
--
CCL2
--
e23
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m23
0
infinite
0
--
CCL11
--
e24
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m24
0
infinite
0
--
CCL5
--
e25
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m25
0
infinite
0
--
TNF
--
e26
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m26
0
infinite
0
--
TNF
--
e27
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
Il-1beta
--
e28
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
Il-1b
--
e29
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
CCL2
--
e30
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m30
0
infinite
0
--
csml-variable:Double
m31
0
infinite
0
--
CCL11
--
e32
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m32
0
infinite
0
--
Il-8
--
e33
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m33
0
infinite
0
--
IL-8
--
e34
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m34
0
infinite
0
--
Zymosan
--
e35
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m35
0
infinite
0
--
TLR2
--
e36
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m36
0
infinite
0
--
Resistin
--
e37
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m37
0
infinite
0
--
AdipoR1
--
e38
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
AdipoR2
--
e39
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
gC1q
--
e40
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m40
0
infinite
0
--
gC1q:AdipoR1
--
e41
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m41
0
infinite
0
--
gc1q:AdipoR2
--
e42
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m42
0
infinite
0
--
Adiponectin
--
e43
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m43
0
infinite
0
--
AdipoR1:Adiponectin
--
e44
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
AdipoR2:Adiponectin
--
e45
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
AMPK
--
e46
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
AMPK{active}
--
e47
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m47
0
infinite
0
--
p38 MAPK
--
e48
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m48
0
infinite
0
--
p38 MAPK{active}
--
e49
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m49
0
infinite
0
--
--
e5
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Endosome
--
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
--
e6
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeLumen
--
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
ACC
--
e63
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m63
0
infinite
0
--
ACC{p}
--
e64
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m64
0
infinite
0
--
CTRP1
--
e65
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m65
0
infinite
0
--
CTRP1
--
e66
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m66
0
infinite
0
--
csml-variable:Double
m67
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
fatty acid
--
e70
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m70
0
infinite
0
--
fatty acid{oxidized}
--
e71
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m71
0
infinite
0
--
CTRP3
--
e72
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m72
0
infinite
0
--
ERK1
--
e73
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m73
0
infinite
0
--
ERK1{active}
--
e74
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m74
0
infinite
0
--
ERK2
--
e75
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m75
0
infinite
0
--
ERK2{active}
--
e76
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m76
0
infinite
0
--
AKT
--
e77
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m77
0
infinite
0
--
AKT{active}
--
e78
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m78
0
infinite
0
--
CTRP3 trimer
--
e79
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m79
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
PPAR-gamma
--
e80
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m80
0
infinite
0
--
csml-variable:Double
m81
0
infinite
0
--
csml-variable:Double
m82
0
infinite
0
--
csml-variable:Double
m83
0
infinite
0
--
Troglitazone
--
e84
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m84
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m12*m13*0.1
nodelay
--
0
PMID: 17681884,16902195,17038530 Synthetic CpG oligodeoxydinucleotide, a TLR9 ligand, can affect mesenchymal stem-cell proliferation and Pam3Cys, a prototypic TLR2 ligand, inhibits adipogenic differentiation of mesenchymal stem cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m33*0.1
nodelay
--
0
PMID: 17681884,16873530,17090751 The proinflammatory response capacity of adipose tissue to LPS, such as the induction of IL-6, TNF, IL-1b, IL-8 and CCL2 secretion, seems to be based mainly on preadipocytes rather than on mature adipocytes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c31 : 1
stoichiometry:c30 : 1
m36*m20*0.1
nodelay
--
0
PMID: 17681884,17090751,10823826 Stimulation with bacterial LPS, yeast cell wall zymosan or TNF of murine and human adipocytes leads to a dramatic induction of TLR2 synthesis indicating that TLR4 signaling in adipocytes induces TLR2 production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c33 : 1
stoichiometry:c34 : 1
m35*m36*0.1
nodelay
--
0
PMID: 17681884,17090751,10823826 Stimulation with bacterial LPS, yeast cell wall zymosan or TNF of murine and human adipocytes leads to a dramatic induction of TLR2 synthesis indicating that TLR4 signaling in adipocytes induces TLR2 production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c36 : 1
stoichiometry:c37 : 1
m36*m27*0.1
nodelay
--
0
PMID: 17681884,17090751,10823826 Stimulation with bacterial LPS, yeast cell wall zymosan or TNF of murine and human adipocytes leads to a dramatic induction of TLR2 synthesis indicating that TLR4 signaling in adipocytes induces TLR2 production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c39 : 1
stoichiometry:c40 : 1
m37*m36*0.1
nodelay
--
0
PMID: 17681884,17062773 Moreover, in human adipocytes, the proinflammatory adipokine resistin induces TLR2 protein expression
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c42 : 1
stoichiometry:c43 : 1
m40*m38*0.1
nodelay
--
0
PMID: 17681884 Interestingly, there is also evidence for a dichotomy of the gC1q?receptor interaction because there are two high- and low-affinity receptors for gC1q and full-length adiponectin: AdipoR1 and AdipoR2 (adiponectin receptors type 1 and type 2).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c44 : 1
stoichiometry:c46 : 1
m39*0.1
nodelay
--
0
PMID: 17681884 Interestingly, there is also evidence for a dichotomy of the gC1q?receptor interaction because there are two high- and low-affinity receptors for gC1q and full-length adiponectin: AdipoR1 and AdipoR2 (adiponectin receptors type 1 and type 2).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c48 : 1
stoichiometry:c49 : 1
m38*m43*0.1
nodelay
--
0
PMID: 17681884 Interestingly, there is also evidence for a dichotomy of the gC1q?receptor interaction because there are two high- and low-affinity receptors for gC1q and full-length adiponectin: AdipoR1 and AdipoR2 (adiponectin receptors type 1 and type 2).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c51 : 1
stoichiometry:c52 : 1
m39*m43*0.1
nodelay
--
0
PMID: 17681884 Interestingly, there is also evidence for a dichotomy of the gC1q?receptor interaction because there are two high- and low-affinity receptors for gC1q and full-length adiponectin: AdipoR1 and AdipoR2 (adiponectin receptors type 1 and type 2).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c54 : 1
stoichiometry:c55 : 1
m41*m46*0.1
nodelay
--
0
PMID: 17681884,12802337 These receptors can mediate both adiponectin- and gC1q-induced activation of adenosine monophosphateactivated kinase (AMPK) and p38 mitogen-activated protein kinase (p38 MAPK) and phosphorylation of ACC (acetyl-CoA-carboxylase)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m15*m16*0.1
nodelay
--
0
PMID: 17681884,16902195,17038530 Synthetic CpG oligodeoxydinucleotide, a TLR9 ligand, can affect mesenchymal stem-cell proliferation and Pam3Cys, a prototypic TLR2 ligand, inhibits adipogenic differentiation of mesenchymal stem cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
stoichiometry:c58 : 1
m42*m46*0.1
nodelay
--
0
PMID: 17681884,12802337 These receptors can mediate both adiponectin- and gC1q-induced activation of adenosine monophosphateactivated kinase (AMPK) and p38 mitogen-activated protein kinase (p38 MAPK) and phosphorylation of ACC (acetyl-CoA-carboxylase)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c59 : 1
stoichiometry:c60 : 1
stoichiometry:c61 : 1
m44*m46*0.1
nodelay
--
0
PMID: 17681884,12802337 These receptors can mediate both adiponectin- and gC1q-induced activation of adenosine monophosphateactivated kinase (AMPK) and p38 mitogen-activated protein kinase (p38 MAPK) and phosphorylation of ACC (acetyl-CoA-carboxylase)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c63 : 1
stoichiometry:c64 : 1
m45*m46*0.1
nodelay
--
0
PMID: 17681884,12802337 These receptors can mediate both adiponectin- and gC1q-induced activation of adenosine monophosphateactivated kinase (AMPK) and p38 mitogen-activated protein kinase (p38 MAPK) and phosphorylation of ACC (acetyl-CoA-carboxylase)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c66 : 1
stoichiometry:c67 : 1
m41*m48*0.1
nodelay
--
0
PMID: 17681884,12802337 These receptors can mediate both adiponectin- and gC1q-induced activation of adenosine monophosphateactivated kinase (AMPK) and p38 mitogen-activated protein kinase (p38 MAPK) and phosphorylation of ACC (acetyl-CoA-carboxylase)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c69 : 1
stoichiometry:c70 : 1
m42*m48*0.1
nodelay
--
0
PMID: 17681884,12802337 These receptors can mediate both adiponectin- and gC1q-induced activation of adenosine monophosphateactivated kinase (AMPK) and p38 mitogen-activated protein kinase (p38 MAPK) and phosphorylation of ACC (acetyl-CoA-carboxylase)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c72 : 1
stoichiometry:c73 : 1
m44*m48*0.1
nodelay
--
0
PMID: 17681884,12802337 These receptors can mediate both adiponectin- and gC1q-induced activation of adenosine monophosphateactivated kinase (AMPK) and p38 mitogen-activated protein kinase (p38 MAPK) and phosphorylation of ACC (acetyl-CoA-carboxylase)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c75 : 1
stoichiometry:c76 : 1
m45*m48*0.1
nodelay
--
0
PMID: 17681884,12802337 These receptors can mediate both adiponectin- and gC1q-induced activation of adenosine monophosphateactivated kinase (AMPK) and p38 mitogen-activated protein kinase (p38 MAPK) and phosphorylation of ACC (acetyl-CoA-carboxylase)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c78 : 1
stoichiometry:c79 : 1
m41*m63*0.1
nodelay
--
0
p28
p28
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
stoichiometry:c91 : 1
stoichiometry:c92 : 1
m20*m28*m27*0.1
nodelay
--
0
PMID: 17681884,16806199 CTRP-1 is expressed in preadipocytes and upregulated dramatically in rat adipose tissue on LPS stimulation and in adipose tissue of murine models with genetically determined obesity PMID: 17681884,16806199 This LPS effect was mediated by TNF and IL-1b and both of these proinflammatory mediators can induce CTRP-1 expression in adipocytes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c81 : 1
stoichiometry:c82 : 1
m42*m63*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
m18*0.1
nodelay
--
0
PMID: 17681884,17525261 Interestingly, leptin is capable of inducing TLR expression and responsiveness in preadipocytes and mature adipocytes, indicating that this adipokine immunomodulates adipocyte function. In this context, mature adipocytes seem to be responsive to a broader spectrum of TLR ligands than preadipocytes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c84 : 1
stoichiometry:c85 : 1
m44*m63*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m45*m63*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
m65*0.1
nodelay
--
0
PMID: 17681884,16806199 CTRP-1 is expressed in preadipocytes and upregulated dramatically in rat adipose tissue on LPS stimulation and in adipose tissue of murine models with genetically determined obesity PMID: 17681884,16806199 This LPS effect was mediated by TNF and IL-1b and both of these proinflammatory mediators can induce CTRP-1 expression in adipocytes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c118 : 1
stoichiometry:c119 : 1
m67*m46*0.1
nodelay
--
0
PMID: 17681884,15231994 CTRP-2, the mouse paralog most similar to adiponectin, enhances glycogen accumulation and fatty acid oxidation in myotubes by activating the AMPK signaling pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c100 : 1
stoichiometry:c120 : 1
stoichiometry:c98 : 1
m70*m47*0.1
nodelay
--
0
PMID: 17681884,15231994 CTRP-2, the mouse paralog most similar to adiponectin, enhances glycogen accumulation and fatty acid oxidation in myotubes by activating the AMPK signaling pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c102 : 1
stoichiometry:c103 : 1
m72*m73*0.1
nodelay
--
0
PMID: 17681884,16650001 CTRP-3 stimulates the proliferation of mesenchymal chondroprogenitor cells through the activation of ERK1/2 and Akt
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c104 : 1
stoichiometry:c105 : 1
stoichiometry:c106 : 1
m72*m75*0.1
nodelay
--
0
PMID: 17681884,16650001 CTRP-3 stimulates the proliferation of mesenchymal chondroprogenitor cells through the activation of ERK1/2 and Akt
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c108 : 1
stoichiometry:c109 : 1
m72*m77*0.1
nodelay
--
0
PMID: 17681884,16650001 CTRP-3 stimulates the proliferation of mesenchymal chondroprogenitor cells through the activation of ERK1/2 and Akt
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c111 : 1
m72*0.1
nodelay
--
0
PMID: 17681884,17311679 CTRP-3 is a secreted protein, can be detected in human serum and forms stable trimers
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c113 : 1
stoichiometry:c114 : 1
m80*m81*0.1
nodelay
--
0
PMID: 17681884,17299102 Moreover, PPARg activation exerts anti-inflammatory effects and PPARg can bind specifically to the CTRP-3 promoter and inhibit CTRP-3 gene expression when activated by troglitazone, an exogenous PPARg activator
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c9 : 1
stoichiometry:c10 : 1
stoichiometry:c11 : 1
m20*m21*0.1
nodelay
--
0
PMID: 17681884 Preadipocytes can react rapidly (within 4 h) to the TLR4 ligand lipopolysaccharide (LPS) by secreting proinflammatory mediators, such as IL-6 and the chemokines CCL2, CCL5 and CCL11 PMID: 17681884,16873530,17090751 The proinflammatory response capacity of adipose tissue to LPS, such as the induction of IL-6, TNF, IL-1b, IL-8 and CCL2 secretion, seems to be based mainly on preadipocytes rather than on mature adipocytes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c117 : 1
stoichiometry:c115 : 1
m84*0.1
nodelay
--
0
PMID: 17681884,17299102 Moreover, PPARg activation exerts anti-inflammatory effects and PPARg can bind specifically to the CTRP-3 promoter and inhibit CTRP-3 gene expression when activated by troglitazone, an exogenous PPARg activator
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c13 : 1
stoichiometry:c14 : 1
m23*m20*0.1
nodelay
--
0
PMID: 17681884 Preadipocytes can react rapidly (within 4 h) to the TLR4 ligand lipopolysaccharide (LPS) by secreting proinflammatory mediators, such as IL-6 and the chemokines CCL2, CCL5 and CCL11 PMID: 17681884,16873530,17090751 The proinflammatory response capacity of adipose tissue to LPS, such as the induction of IL-6, TNF, IL-1b, IL-8 and CCL2 secretion, seems to be based mainly on preadipocytes rather than on mature adipocytes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c16 : 1
stoichiometry:c20 : 1
m20*m24*0.1
nodelay
--
0
PMID: 17681884 Preadipocytes can react rapidly (within 4 h) to the TLR4 ligand lipopolysaccharide (LPS) by secreting proinflammatory mediators, such as IL-6 and the chemokines CCL2, CCL5 and CCL11
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c19 : 1
stoichiometry:c17 : 1
m25*m20*0.1
nodelay
--
0
PMID: 17681884 Preadipocytes can react rapidly (within 4 h) to the TLR4 ligand lipopolysaccharide (LPS) by secreting proinflammatory mediators, such as IL-6 and the chemokines CCL2, CCL5 and CCL11
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c22 : 1
stoichiometry:c23 : 1
m20*m26*0.1
nodelay
--
0
PMID: 17681884,16873530,17090751 The proinflammatory response capacity of adipose tissue to LPS, such as the induction of IL-6, TNF, IL-1b, IL-8 and CCL2 secretion, seems to be based mainly on preadipocytes rather than on mature adipocytes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c25 : 1
stoichiometry:c26 : 1
m29*m20*0.1
nodelay
--
0
PMID: 17681884,16873530,17090751 The proinflammatory response capacity of adipose tissue to LPS, such as the induction of IL-6, TNF, IL-1b, IL-8 and CCL2 secretion, seems to be based mainly on preadipocytes rather than on mature adipocytes
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--